Nordea Investment Management AB / BMY
Nordea Investment Management AB’s Bristol-Myers Squibb Co Position
Does Nordea Investment Management AB own Bristol-Myers Squibb Co (BMY)? Yes — 2.03M shares worth $122M (+0.11% of its 13F portfolio) as of Q1 2026, up from 200.3K shares the prior filed quarter.
Position Value
$122M
Q1 2026
Shares
2.03M
% of Portfolio
+0.11%
Quarters Held
30
currently held
Position History BMY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 2.03M | $122M | +0.11% |
| Q4 2025 | 200.3K | $11M | +0.01% |
| Q3 2025 | 520.1K | $23M | +0.02% |
| Q2 2025 | 502.7K | $23M | +0.02% |
| Q1 2025 | 625.1K | $38M | +0.04% |
| Q4 2024 | 5.51M | $311M | +0.33% |
| Q3 2024 | 6.32M | $325M | +0.37% |
| Q2 2024 | 5.77M | $243M | +0.29% |
| Q1 2024 | 7.69M | $416M | +0.49% |
| Q4 2023 | 11.12M | $570M | +0.72% |
| Q3 2023 | 11.68M | $681M | +0.95% |
| Q2 2023 | 12.06M | $774M | +1.06% |
| Q1 2023 | 12.07M | $834M | +1.22% |
| Q4 2022 | 11.21M | $803M | +1.25% |
| Q3 2022 | 11.72M | $840M | +1.36% |
| Q2 2022 | 13.06M | $1.0B | +1.49% |
| Q1 2022 | 15.40M | $1.1B | +1.42% |
| Q4 2021 | 18.13M | $1.1B | +1.36% |
| Q3 2021 | 15.01M | $907M | +1.18% |
| Q2 2021 | 15.00M | $1.0B | +1.34% |
| Q1 2021 | 13.56M | $854M | +1.24% |
| Q4 2020 | 13.23M | $821M | +1.32% |
| Q3 2020 | 13.24M | $793M | +1.49% |
| Q2 2020 | 19.62M | $1.1B | +1.17% |
| Q1 2020 | 9.96M | $551M | +1.33% |
| Q4 2019 | 9.82M | $625M | +1.25% |
| Q3 2019 | 11.77M | $604M | +1.32% |
| Q2 2019 | 7.69M | $349M | +0.78% |
| Q1 2019 | 6.25M | $298M | +0.62% |
| Q4 2018 | 3.91M | $203M | +0.17% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Nordea Investment Management AB’s full portfolio or all institutional holders of BMY.